2023 - Research.com Molecular Biology in Australia Leader Award
2021 - Fellow of the Australian Academy of Health and Medical Science
2008 - Member of the National Academy of Sciences
1994 - ACM Fellow For his outstanding contributions over many years in inspiring and supporting ACM's volunteers, in serving as ACM's collective conscience and memory, and in uniting the volunteers and the professional staff into a single team working to fulfill ACM's potential.
1992 - Fellow of the Royal Society, United Kingdom
1992 - Outstanding Contribution to ACM Award For his outstanding contributions over many years in inspiring and supporting ACM's volunteers, in serving as ACM's collective conscience and memory, and in uniting the volunteers and the professional staff into a single team working to fulfill ACM's potential.
1986 - Fellow of the Australian Academy of Science
Fellow of the Royal Society of South Africa
Jerry M. Adams mainly focuses on Cell biology, Apoptosis, Programmed cell death, BH3 Mimetic ABT-737 and Tissue homeostasis. His research integrates issues of Caspase, Peptide sequence, Puma and Protein family in his study of Cell biology. His Apoptosis study combines topics in areas such as Proteases, Cancer and MAPK/ERK pathway.
Jerry M. Adams has researched Programmed cell death in several fields, including Cancer research and Immunology. The Cancer research study combines topics in areas such as Cell culture and Lymphoma. His BH3 Mimetic ABT-737 research incorporates themes from Cell cycle and Bcl-2 Homologous Antagonist-Killer Protein.
Jerry M. Adams spends much of his time researching Molecular biology, Cell biology, Apoptosis, Cancer research and Gene. His Molecular biology research includes themes of Transgene, Immunoglobulin heavy chain, Chromosomal translocation, RNA and Oncogene. His Cell biology research is multidisciplinary, incorporating perspectives in Caspase, Tissue homeostasis and Cytokine.
His work on Programmed cell death, Bcl-2 family and Puma as part of general Apoptosis research is frequently linked to Bcl-2-associated X protein, bridging the gap between disciplines. Jerry M. Adams interconnects Carcinogenesis, Cancer, Haematopoiesis, Lymphoma and Genetically modified mouse in the investigation of issues within Cancer research. Jerry M. Adams has included themes like Antibody and DNA in his Gene study.
Jerry M. Adams focuses on Apoptosis, Cancer research, Cell biology, Programmed cell death and Bcl-2-associated X protein. His Apoptosis research includes elements of Cell, Haematopoiesis, Cell culture, Cytokine and Protein family. The Cancer research study combines topics in areas such as Cancer, Immunology, Lymphoma, Venetoclax and Genetically modified mouse.
Jerry M. Adams usually deals with Cell biology and limits it to topics linked to Carcinogenesis and Progenitor cell. His Programmed cell death research focuses on Tissue homeostasis and how it connects with Signal transduction. His studies in Mitochondrion integrate themes in fields like Caspase, Activator and Cytosol.
His main research concerns Apoptosis, Cell biology, Cancer research, Programmed cell death and Mitochondrion. His Apoptosis study frequently links to adjacent areas such as Protein family. His Cell biology study combines topics in areas such as Cell, Tissue homeostasis, Carcinogenesis, Peptide sequence and Bcl-2 family.
His Cancer research study integrates concerns from other disciplines, such as Venetoclax, Chronic lymphocytic leukemia and Cancer. His work carried out in the field of Chronic lymphocytic leukemia brings together such families of science as Myeloid, Cancer development and BH3 Mimetic ABT-737. As a part of the same scientific family, Jerry M. Adams mostly works in the field of Mitochondrion, focusing on Protein structure and, on occasion, Bcl-2 Homologous Antagonist-Killer Protein, Biophysics and Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Bcl-2 Protein Family: Arbiters of Cell Survival
Jerry M. Adams;Suzanne Cory.
The Bcl2 family: regulators of the cellular life-or-death switch.
Suzanne Cory;Jerry M. Adams.
Nature Reviews Cancer (2002)
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
David L. Vaux;Suzanne Cory;Jerry M. Adams.
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Peter E Czabotar;Guillaume Lessene;Andreas Strasser;Jerry M Adams.
Nature Reviews Molecular Cell Biology (2014)
The Bcl-2 apoptotic switch in cancer development and therapy
J M Adams;S Cory.
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
Lin Chen;Simon N. Willis;Andrew Wei;Brian J. Smith.
Molecular Cell (2005)
The c- myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
J. M. Adams;A. W. Harris;C. A. Pinkert;L. M. Corcoran.
The Bcl-2 family: roles in cell survival and oncogenesis.
Suzanne Cory;David C S Huang;Jerry M Adams.
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.
Philippe Bouillet;Donald Metcalf;David C. S. Huang;David M. Tarlinton.
p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.
Andreas Villunger;Andreas Villunger;Ewa M. Michalak;Leigh Coultas;Franziska Müllauer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: